Association of oral endothelin receptor antagonists with risks of cardiovascular events and mortality: meta-analysis of randomized controlled trials

被引：0
|
作者：
Yu Pan
Chun Hu
Pei Hua Chen
Yan Hong Gu
Qing Yan Qiao
Li Hua Pan
Dong Chi Zhou
Hui Fang Gu
Shun Kun Fu
Hui Min Jin
机构：
[1] Shanghai Jiaotong University,Division of Nephrology, Shanghai Ninth People’s Hospital, School of Medicine
[2] Fudan University,Division of Nephrology, Shanghai Pudong Hospital
[3] Pudong Medical Center,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Oral endothelin receptor antagonist; Cardiovascular events; All-cause mortality; Major adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：267 / 278
页数：11
相关论文
共 50 条
  • [31] Assessing the risk of angiotensin receptor blockers on major cardiovascular events: a systematic review and meta-analysis of randomized controlled trials
    Yara Wanas
    Rim Bashir
    Nazmul Islam
    Luis Furuya-Kanamori
    BMC Cardiovascular Disorders, 20
  • [32] Effects of mineralocorticoid receptor antagonists on the risk of mortality, thrombosis and bleeding in patients with secondary hyperaldosteronism: a meta-analysis of randomized controlled trials
    Elbers, L.
    Sjouke, B.
    Gerdes, V. E.
    Squizzato, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 519 - 519
  • [33] Cardiovascular Events and Safety Outcomes Associated with Azithromycin Therapy: A Meta-Analysis of Randomized Controlled Trials
    Almalki, Ziyad S.
    Guo, Jeff Jianfei
    AMERICAN HEALTH AND DRUG BENEFITS, 2014, 7 (06): : 318 - 328
  • [34] Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis of randomized controlled trials
    Berwanger, Otavio
    Oliveira, Joao Bosco
    Suzumura, Erica
    Buhler, Anna M.
    Oliveira, Dinaldo
    Marx, Carlos B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A365 - A365
  • [35] Aspirin in primary prevention of cardiovascular events in women and men - (A meta-analysis of randomized controlled trials)
    Yavelov, I. S.
    KARDIOLOGIYA, 2006, 46 (03) : 75 - 76
  • [36] Proton-Pump Inhibitors and Cardiovascular Adverse Events: A Meta-Analysis of Randomized Controlled Trials
    Mosholder, Andrew D.
    Hada, Manila
    Leishear, Kira
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (02): : 362 - 369
  • [37] Nicotinic acid in the prevention of cardiovascular events: A meta-analysis of randomized placebo-controlled trials
    Singh, Sarabjeet
    Attri, Navneet
    Arora, Rohiff
    Molnar, Janos
    Duggal, Jasleen
    Khraisat, Ahmad
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A365 - A365
  • [38] Aspirin for Primary Prevention of Cardiovascular Events in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Trials
    De Berardis, Giorgia
    Sacco, Michele
    Graziano, Giusi
    Pellegrini, Fabio
    Nicolucci, Antonio
    DIABETES, 2009, 58 : A24 - A24
  • [39] Vasopressin Antagonists for Heart Failure: A Meta-Analysis of Randomized Controlled Trials
    Wang, Na
    Jia, Chaoxia
    Liu, Chao
    Du, Fenghe
    CIRCULATION, 2010, 122 (02) : E223 - E224
  • [40] Effect of metformin on all-cause mortality and major adverse cardiovascular events: An updated meta-analysis of randomized controlled trials
    Monami, Matteo
    Candido, Riccardo
    Pintaudi, Basilio
    Targher, Giovanni
    Mannucci, Edoardo
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (03) : 699 - 704
12345